中
About
Our Mission & Vision
Team
Leadership
Board of Directors
Milestones
Pipeline
Ophthalmology
Business Development
Business Development
Newsroom
Press Releases
In The News
Media Room
Careers
Value & Behaviors
Benefits
Open Positions
Contact
About
Our Mission & Vision
Team
Milestones
Pipeline
Ophthalmology
Business Development
Business Development
Newsroom
Press Releases
In The News
Media Room
Careers
Value & Behaviors
Benefits
Open Positions
Contact
中
News
Press Releases
In The News
Media Room
May 31,2023
31
May 2023
AffaMed Therapeutics Announces Completion of Patient Enrollment in the Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA
®
in Cataract Surgery Patients
May 25,2023
25
May 2023
AffaMed Therapeutics Announces Partner Allgenesis Reports Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema
Apr 17,2023
17
April 2023
AffaMed Therapeutics Announces Approval to Initiate a Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA
®
for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery
Mar 20,2023
20
March 2023
AffaMed Technologies Announces TFDA Approval of MINI WELL, MINI WELL PROXA, MINI WELL TORIC and MINI 4 Ready IOLs for Cataract Treatment in Taiwan
Mar 03,2023
03
March 2023
AffaMed Technologies Announces the First Implantation in the China Registrational Clinical Trial of MINI WELL
®
, the Progressive Extended Depth-of-Focus IOL
<<
<
1
2
3
4
5
6
>
>>
上一页
下一页
